Bristol-Myers Squibb Company 8-K 2010
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 4, 2010
BRISTOL-MYERS SQUIBB COMPANY
(Exact Name of Registrant as Specified in its Charter)
345 Park Avenue
New York, NY, 10154
(Address of Principal Executive Office)
Registrants telephone number, including area code: (212) 546-4000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
On March 4, 2010, the Company issued a press release in conjunction with a meeting with investors announcing, among other things, that it is providing minimum non-GAAP earnings per share guidance for 2013, subject to certain exclusions and assumptions. There is no reasonably accessible or reliable comparable GAAP measure for this forward-looking information on earnings per share. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.